S N Binkley
- Pharmacology top 0.5%
- Oncology top 10%
- Computational Theory and Mathematics top 5%
- Molecular Biology
- Pharmacology top 10%
- Co-authors
- Steven WrightonBarbara J. RingMark VandenBrandenJennifer S. GillespieSean EkinsLisa A. ShipleyGianpaolo BraviJames J. Starling
- Topics
- Pharmacogenetics and Drug Metabolism (9 papers)Drug Transport and Resistance Mechanisms (4 papers)Analytical Chemistry and Chromatography (2 papers)
- Journals
- Journal of Pharmacology and Experimental TherapeuticsBritish Journal of Clinical PharmacologyDrug Metabolism and Disposition
- Partner nations
- United States
In The Last Decade
S N Binkley
10 papers receiving 777 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 500
- Oncology 337
- Computational Theory and Mathematics 178
- Molecular Biology 173
- Pharmacology 139
Countries citing papers authored by S N Binkley
This map shows the geographic impact of S N Binkley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S N Binkley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S N Binkley more than expected).
Fields of papers citing papers by S N Binkley
This network shows the impact of papers produced by S N Binkley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S N Binkley. The network helps show where S N Binkley may publish in the future.
Co-authorship network of co-authors of S N Binkley
This figure shows the co-authorship network connecting the top 25 collaborators of S N Binkley. A scholar is included among the top collaborators of S N Binkley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S N Binkley. S N Binkley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 72 | |
| 3 | 81 | |
| 4 | Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. | 72 |
| 5 | 149 | |
| 6 | Autoactivation and activation of the cytochrome P450s. | 63 |
| 7 | 93 | |
| 8 | 75 | |
| 9 | 54 | |
| 10 | 146 |
About S N Binkley
S N Binkley is a scholar working on Pharmacology, Physiology and Oncology, having authored 10 papers that have together received 813 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (4 papers) and Analytical Chemistry and Chromatography (2 papers). The work is most often cited by research in Pharmacology (500 citations), Oncology (337 citations) and Computational Theory and Mathematics (178 citations). S N Binkley has collaborated with scholars based in United States. Frequent co-authors include Steven Wrighton, Barbara J. Ring, Mark VandenBranden, Jennifer S. Gillespie, Sean Ekins, Lisa A. Shipley, Gianpaolo Bravi, James J. Starling, Linda B. Tabas and Anne H. Dantzig. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.